Literature DB >> 2187801

Effect of proteolytic activity on virulence of Candida albicans in burned mice.

A N Neely1, I A Holder.   

Abstract

Total circulating proteolytic activity (PA) was determined by measuring the acid-soluble 125I-protein fragments generated per 100 microliters of serum incubated with 125I-protein at 37 degrees C for 15 min. Normal mice had low circulating PA (1.3 +/- 0.2 micrograms/100 microliters), and burned mice had a higher average PA; the actual value depended on the time of measurement postburn. We measured the effect on mortality and on circulating PA of challenging normal and burned mice with high-virulence strain Candida albicans MY 1044 and its less virulent mutant MY 1049. Burned and normal mice challenged with a high dose (10(5)) of MY 1044 had high mortality (greater than 90%) and high circulating PA (greater than 33 micrograms generated per 100 microliters). Burned mice challenged with a lower dose (10(4] of MY 1044 had moderate mortality (63%) and lower PA (27.2 +/- 4.2 micrograms/100 microliters). All other groups of mice, including burned mice challenged with 10(5) MY 1049, had low mortality (less than 10%), and PAs were less than 22 micrograms/100 microliters. Augmentation of burned mice challenged with 10(5) MY 1049 with proteinase significantly increased mortality; with treatment of burned mice challenged with 10(5) MY 1044 with proteinase inhibitor significantly decreased mortality. We conclude that mortality correlated with total circulating PA; that the contribution to this net PA was the background PA level in the normal mice, the PA associated with the burn, and the PA caused by infection with a C. albicans strain with a particular virulence; that most deaths caused by C. albicans occurred past a PA threshold of 25 micrograms/100 microliters in the host; and that the number of burned and infected mice that died of candidiasis could be modulated by the addition of proteinases or proteinase inhibitors to the host. This last finding may lead to some novel treatments for candidiasis in burned hosts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187801      PMCID: PMC258666          DOI: 10.1128/iai.58.6.1527-1531.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  A rationale for the therapeutic action of aprotinin.

Authors:  G Haberland; R McConn
Journal:  Fed Proc       Date:  1979-12

2.  A rapid and sensitive proteolytic assay for human plasminogen and plasmin using radioiodinated alpha-casein.

Authors:  R F Highsmith; R D Rosenberg
Journal:  Thromb Res       Date:  1977-08       Impact factor: 3.944

3.  Experience with systemic candidiasis in the burned patient.

Authors:  E J Law; O J Kim; D D Stieritz; B G MacMillan
Journal:  J Trauma       Date:  1972-07

4.  An examination of the production of hydrolytic enzymes and toxins by pathogenic strains of Candida albicans.

Authors:  F W Chattaway; F C Odds; A J Barlow
Journal:  J Gen Microbiol       Date:  1971-08

5.  The effect of thermal injury on serum immunoglobulins.

Authors:  A M Munster; H C Hoagland; B A Pruitt
Journal:  Ann Surg       Date:  1970-12       Impact factor: 12.969

6.  Lethality of Candida strains as influenced by the host.

Authors:  C G Saltarelli; K A Gentile; S C Mancuso
Journal:  Can J Microbiol       Date:  1975-05       Impact factor: 2.419

Review 7.  Alpha 2-macroglobulin.

Authors:  A J Barrett
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

8.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model.

Authors:  D D Stieritz; I A Holder
Journal:  J Infect Dis       Date:  1975-06       Impact factor: 5.226

9.  Candidiasis in the burned patient.

Authors:  M J Spebar; B A Pruitt
Journal:  J Trauma       Date:  1981-03

Review 10.  Fungal infections in the immunocompromised host.

Authors:  D K Stein; A M Sugar
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Jul-Aug       Impact factor: 2.803

View more
  8 in total

1.  Effect of challenge with Candida albicans strains with different levels of virulence on plasma proteins in burned mice.

Authors:  A N Neely; C M Childress; I A Holder
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

2.  Extracellular proteinase activity of Cryptococcus neoformans.

Authors:  L C Chen; E S Blank; A Casadevall
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

Review 3.  Nonculture methods for diagnosis of disseminated candidiasis.

Authors:  E Reiss; C J Morrison
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

4.  Effect of thermal injury on the adherence of Candida albicans to murine splenic tissue.

Authors:  A N Neely; M M Orloff; I A Holder; D P Healy
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

Review 5.  Fungal proteases and their pathophysiological effects.

Authors:  Iwona Yike
Journal:  Mycopathologia       Date:  2011-01-23       Impact factor: 2.574

6.  Candida albicans produces a cystatin-type cysteine proteinase inhibitor.

Authors:  H Tsushima; H Mine; K Hoshika; Y Kawakami; F Hyodoh; A Ueki
Journal:  J Bacteriol       Date:  1992-07       Impact factor: 3.490

7.  Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition.

Authors:  A N Neely; R G Miller; I A Holder
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  Degradation of humoral host defense by Candida albicans proteinase.

Authors:  H Kaminishi; H Miyaguchi; T Tamaki; N Suenaga; M Hisamatsu; I Mihashi; H Matsumoto; H Maeda; Y Hagihara
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.